Application of the French guidelines for preventing neonatal group B streptococcal disease in a university hospital

Clinical Microbiology and Infection

Volumn 13, Issue 3, 2007, Pages 322-324

  Mereghetti, Laurent ^a,b   Lanotte, P ^a,b   Rochoux, A ^c   Sauget, A S ^a   Chevillot, M ^c   Perrotin, F ^c   Follet, C ^c   Saliba, E ^c   Quentin, R ^b   Lansac, J ^c   Goudeau, A ^a  

^a CHU BRETONNEAU   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

Colonisation; Group B streptococcus; Guidelines; Neonatal infection; Streptococcus agalactiae; Vaginal carriage

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; PENICILLIN G; SPIRAMYCIN;

ARTICLE; BACTERIAL COLONIZATION; CLINICAL PROTOCOL; DRUG HYPERSENSITIVITY; FEMALE; FRANCE; HUMAN; INFECTION PREVENTION; LABOR; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INFECTION; NONHUMAN; PRACTICE GUIDELINE; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; SCREENING; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; UNIVERSITY HOSPITAL;

STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 34247189199     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01619.x     Document Type: Article

References (13)

1. Dutch Organisation of Obstetrics and Gynaecology. Prevention of perinatal group B streptococcal disease. Gynaecology guideline 12. Utrecht: NVOG, 1998.
2. Schrag SJ, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease: Revised guidelines from CDC. MMWR Recomm Rep 2002; 51: 1-22.
3. Anonymous. Prévention des infections périnatales àstreptocoques du groupe B. Recommandations Du Conseil Supérieur d'Hygiène de Belgique. Brussels: Conseil Supefieur d'Hygiène de Belgique, 2003.
4. Health Protection Agency GBS Working Group. Interim 'good practice'recommendations for the prevention of early onset neonatal group B streptococcal infection in the United Kingdom. London: Health Protection Agency, 2004.
5. Campbell N, Eddy A, Darlow B, Stone P, Grimwood K. The prevention of early-onset neonatal group B streptococcus infection: Technical report from the New Zealand GBS Consensus Working Group Party. NZ Med J 2004; 117: 1-19.
6. Anonymous. Prévention anténatale du risque infectieux bactérien néonatal précoce. Recommendations pour la pratique clinique. Paris: Agence Nationale d'Accréditation et d'Evaluation en Santé, 2001.
7. Gotoff SP. Group B streptococcal infections. Pediatr Res 2002; 23: 381-386.
8. Loulergue J, CouhéC, Grasmick C, Laudat P, Quentin R. Sensibilitéaux antibiotiques des souches de streptocoque du groupe B de portage vaginal isolées en France, 2003. Bull Epidemiol Hebdom 2004; 18: 69-70.
9. Chhhuy T, Mansour G, Zejli A, Bouquigny C, Bock S, Abboud P. Group B streptococcus screening: A retrospective study in 1,674 pregnancies. J Gynecol Obstet Biol Reprod 2005; 34: 328-333.
10. Jauréguy F, Carton M, Teboul J et al. Risk factors and screening strategy for group B streptococcal colonization in pregnant women: results of a prospective study. J Gynecol Obstet Biol Reprod 2003; 32: 132-138.
11. Benitz WE, Gould JB, Druzin ML. Preventing early-onset group B streptococcal sepsis: Strategy development using decision analysis. Pediatrics 1999; 103: E76.
12. Hansen SM, Uldbjerg N, Kilian M, Sorensen UB. Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants. J Clin Microbiol 2004; 42: 83-89.
13. de Cueto M, Sanchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa-Fraile M. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol 1998; 91: 112-114.